MAI Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
MAI Capital Management's FBT Position: Q2 2026 in Review
MAI Capital Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 4.8% in Q2 2026, selling an estimated $82.1K and leaving 7,625 shares worth $1.89M. The position accounts for 0.01% of the portfolio, ranked #724.
MAI Capital Management first reported a position in FBT in Q4 2021 and has held it in 19 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- MAI Capital Management held 7,625 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.89M as of Q2 2026.
- MAI Capital Management sold 381 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $82.1K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of MAI Capital Management's portfolio in Q2 2026, its #724 holding.
- MAI Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and has held it in 19 quarters since.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.